Aspirin synergistically potentiates isofiurane minimum alveolar concentration reduction produced by morphine in the rat

Anesthesiology

Volumn 89, Issue 6, 1998, Pages 1489-1494

  Gomez De Segura, Ignacio A ^b   Criado, Ana B ^c   Santos, Martin ^c   Tendillo, Francisco J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c NONE

Author keywords

Analgesics; Animals; Inhalational anesthetics

Indexed keywords

ACETYLSALICYLIC ACID; ISOFLURANE; MORPHINE;

ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY FUNCTION;

ANALGESICS, OPIOID; ANESTHETICS, INHALATION; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG SYNERGISM; ELECTROCARDIOGRAPHY; HEMODYNAMIC PROCESSES; ISOFLURANE; MALE; MORPHINE; PULMONARY ALVEOLI; RATS; RATS, WISTAR; RESPIRATORY MECHANICS;

EID: 0344699408     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199812000-00027     Document Type: Article

References (23)

1. Reasbeck PG, Rice ML, Reasbeck JC. Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery. Lancet 1982; 2:115-8
2. Gillies GWA, Kenny GNC, Bullingham RES, McArdle CS: The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987; 42:727-31
3. Burns J, Aitken HA, Bullingham RES, McArdle CS, Kenny GNC: Double-blind comparison of the morphine sparing effect of continuous and intermittent i.m. administration of ketorolac. Br J Anaesth 1991; 67:235-8
4. Laitinen J, Nuutinen L: Intravenous diclofenac coupled with PCA fentanyl for pain relief after total hip replacement. ANESTHESIOLOGY 1992; 76:194-8
5. Beaver WT: Combination analgesics. Am J Med 1984; 77: 38-53
6. Vaughan CW, Ingram SL, Connor MA, Christie MJ: How opioids inhibit GABA-mediated neurotransmission. Nature 1997; 390: 611-4
7. Williams T: The painless synergism of aspirin and opioum. Nature 1997; 390:557-8
8. Stoelting RK: Opioid agonists and antagonists, Pharmacology and Physiology in Anesthetic Practice. 2nd edition. Philadelphia, JB Lippincott, 1991
9. Brooks JA, Wood AJJ: Nonsteroidal antiinflamatory drugs - Differences and similarities. New Engl J Med 1991; 324:1716-25
10. Maves TJ, Pechman PS, Meller ST, Gebhart GF: Ketorolac potentiates morphine antinociception during visceral nociception in the rat. ANESTHESIOLOGY 1994; 80:1094-101
11. Pajewski TN, DiFazio CA, Moscicki JC, Johns RA: Nitric oxide synthase inhibitors, 7-nitro indazole and nitro-G-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia ANESTHESIOLOGY 1996; 85:1111-9
12. Eger E II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: A standard of anesthetic potency. ANESTHESIOLOGY 1965; 26:756-63
13. Moss JT, Baysinger CL, Boswell GW, Sayson S: Possible intraoperative anesthetic-sparing effect of parenteral ketorolac Ann Pharmacother 1992; 26:922-4
14. Green CR, Pandit SK, Levy L, Kothary SP, Tait AR, Schork MA: Intraoperative ketorolac has an opioid-sparing effect in women after diagnostic laparoscopy but not after laparoscopic tubal ligation. Anesth Analg 1996; 82:732-7
15. Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. ANESTHESIOLOGY 1993; 79:211-3
16. Foley KM: The treatment of cancer pain. N Engl J Med 1985; 313:84-95
17. Cashman JN: The mechanisms of action of NSAIDs in analgesia. Drugs 1996; 52:13-23
18. Higuchi S, Tanaka N, Shioiri Y, Otomo S, Aihara H: Two modes of analgesic action of aspirin, and the site of analgesic action of salicylic acid. Int J Tissue React 1986; 8:327-31
19. Seibert K, Zhinag Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 1994; 91:12013-7
20. Capogna M, Gahwiler BH, Thompson SM: Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J Physiol (Lond) 1993; 470:539-58
21. Rampil IJ, King BS: Volatile anesthetics depress spinal motor neurons. ANESTHESIOLOGY 1996; 85:129-34
22. Phillips BM, Hartnagel RE, Leeling JL, Gurtoo HL. Does aspirin play a role in analgesic nephropathy? Aust N Z J Med 1976; 6(suppl 1):48-53
23. Burrell JH, Yong JL, Macdonald GJ: Experimental analgesic nephropathy: Changes in renal structure and urinary concentrating ability in Fischer 344 rats given continuous low doses of aspirin and paracetamol. Pathology 1990; 22:33-44